Second-Line Therapy for Metastatic TNBC
Shay Elkins, a patient with triple negative breast cancer, shares her experience of relapse six months post-treatment, eventually leading her to seek a second opinion for her recurring symptoms. Dr. Noor Abuhadra discusses second-line treatment options for metastatic triple negative breast cancer, emphasizing newer therapies like antibody drug conjugates and PARP inhibitors, and highlights the evolving landscape that offers hope for patients.
Shay Elkins Noor Abuhadra Metastatic Triple Negative Breast Cancer Overcoming Challenges Diagnosis Treatment Online Therapy
Source: curetoday.com